WALTHAM, Mass., Sept. 16, 2025 /PRNewswire/ -- Body Vision Medical, a global leader in AI-powered intraoperative imaging, is proud to...
Eliminates PEPM Fees and Rewards Budgets — Helping Employers Save Hundreds of Thousands Annually While Delivering 24/7 "Care in Your...
Ms. Douglas to support patient engagement initiatives, joins Company's Industry Advisory Board TORONTO and DALLAS, Sept. 16, 2025 /PRNewswire/ -...
PPO plan awarded 5 out of 5 stars by The National Committee for Quality Assurance BOSTON, Sept. 16, 2025 /PRNewswire/...
New offering gives health systems a way to determine whether their healthcare data aligns with pharmaceutical demand before engaging or...
Physician specializes in stem cell transplantation for blood cancers DETROIT, Sept. 16, 2025 /PRNewswire/ -- The Barbara Ann Karmanos Cancer...
Ottawa, Ontario--(Newsfile Corp. - September 16, 2025) - When medical screening guidelines fail to prioritize early detection, they put Canadians...
No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently favorable safety and tolerabilityTrial progressing...
Honors IMF NLB Member Dr. Beth Faiman as First Recipient During the Inauguration and Awards CeremonyCLEVELAND, Ohio, Sept. 16, 2025...
VANCOUVER, Washington, Sept. 16, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing...
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement...
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement...
New Taipei City, Taiwan, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a...
New Taipei City, Taiwan, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a...
Lead product candidate will be advanced to late IND-enabling studies to prepare for clinical trials for evaluation in the treatment of...
Lead product candidate will be advanced to late IND-enabling studies to prepare for clinical trials for evaluation in the treatment of...
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- via IBN –Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF)...
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- via IBN –Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF)...
Dose optimization data from the Phase 1/2 study to be presented next month at ESMO 2025Second Fast Track designation granted...
Dose optimization data from the Phase 1/2 study to be presented next month at ESMO 2025Second Fast Track designation granted...